Related Experiment Video
Updated: Aug 24, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
A Case of Anti-SRP Immune-mediated Necrotizing Myopathy Following Suspected Coxsackie B4 Infection: Exploring a Viral
Marwan Ahmed1, Ruba Salameh1, Soziema Salia1
1Department of Internal Medicine, MedStar Health, Baltimore, MD, USA.
Abstract:
Immune-mediated necrotizing myopathy (IMNM) is a rare subtype of idiopathic inflammatory myopathies that can present with rhabdomyolysis. We report a 43-year-old woman with rapidly progressive proximal muscle weakness following a flu-like illness. Laboratory evaluation revealed markedly elevated creatine kinase (22,207 U/L) and transaminases, with positive anti-signal recognition particle (SRP) and Coxsackie B4 antibodies. Muscle biopsy demonstrated extensive necrosis, regeneration, and endomysial lymphocytic infiltration, confirming IMNM. The patient was treated with intravenous methylprednisolone, IVIG, and rituximab, followed by oral steroid taper and mycophenolate. At six-month follow-up, she showed significant clinical and biochemical improvement. This case highlights a potential viral-triggered autoimmune mechanism, suggesting that Coxsackie B4 infection may initiate or amplify anti-SRP-mediated immune muscle injury. Greater awareness of viral associations may aid early diagnosis and targeted therapy of IMNM.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Respiratory Syncytial Virus Disease
Viral Meningitis
Poliomyelitis
Encephalitis ll: Pathophysiology